Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 105 points (-0.6%) at 17,744 as of Wednesday, March 18, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,422 issues advancing vs. 1,524 declining with 171 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is down 0.3%. Top gainers within the industry include Centene ( CNC), up 1.3%, and Smith & Nephew ( SNN), up 0.9%. On the negative front, top decliners within the industry include Waters ( WAT), down 1.4%, Grifols ( GRFS), down 1.2%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.2% and Abbott Laboratories ( ABT), down 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Boston Scientific ( BSX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Boston Scientific is up $0.10 (0.6%) to $17.50 on average volume. Thus far, 5.8 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 12.8 million shares. The stock has ranged in price between $17.30-$17.61 after having opened the day at $17.32 as compared to the previous trading day's close of $17.40.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Boston Scientific has a market cap of $22.9 billion and is part of the health care sector. Shares are up 31.3% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Boston Scientific Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Anthem ( ANTM) is up $1.00 (0.7%) to $154.30 on average volume. Thus far, 704,754 shares of Anthem exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $153.03-$154.45 after having opened the day at $153.03 as compared to the previous trading day's close of $153.30.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $40.9 billion and is part of the health care sector. Shares are up 22.0% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts who rate Anthem a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Anthem as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Anthem Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCA Holdings ( HCA) is up $0.80 (1.1%) to $73.96 on light volume. Thus far, 716,003 shares of HCA Holdings exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $73.05-$73.99 after having opened the day at $73.05 as compared to the previous trading day's close of $73.16.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $30.8 billion and is part of the health care sector. Shares are down 0.3% year-to-date as of the close of trading on Tuesday. Currently there are 16 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, revenue growth, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null